home / stock / gmab / gmab quote
Last: | $ |
---|---|
Change Percent: | -2.01% |
Open: | $24.00 |
Close: | $23.84 |
High: | $24.01 |
Low: | $23.83 |
Volume: | 215,311 |
Last Trade Date Time: | 02/12/2020 04:43:03 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $24.00 | $23.84 | $24.01 | $23.83 | 215,311 | 02-12-2020 |
$ | $24.23 | $24.33 | $24.45 | $24.18 | 182,586 | 02-11-2020 |
$ | $24.00 | $24.19 | $24.225 | $23.94 | 152,683 | 02-10-2020 |
$ | $24.09 | $24.13 | $24.21 | $24.04 | 343,736 | 02-07-2020 |
$ | $23.93 | $24.30 | $24.31 | $23.86 | 769,836 | 02-06-2020 |
$ | $23.98 | $24.10 | $24.24 | $23.90 | 418,600 | 02-05-2020 |
$ | $23.61 | $23.60 | $23.72 | $23.49 | 420,032 | 02-04-2020 |
$ | $23.25 | $23.45 | $23.53 | $23.21 | 198,414 | 02-03-2020 |
$ | $23.15 | $23.21 | $23.33 | $23.0201 | 191,947 | 01-31-2020 |
$ | $23.14 | $23.23 | $23.29 | $23.01 | 221,033 | 01-30-2020 |
$ | $22.81 | $23.01 | $23.13 | $22.70 | 234,812 | 01-29-2020 |
$ | $22.35 | $22.49 | $22.60 | $22.32 | 322,462 | 01-28-2020 |
$ | $22.30 | $22.37 | $22.54 | $22.23 | 275,711 | 01-27-2020 |
$ | $22.74 | $22.57 | $22.86 | $22.51 | 170,875 | 01-24-2020 |
$ | $22.87 | $22.98 | $23.01 | $22.75 | 179,166 | 01-23-2020 |
$ | $22.95 | $23.12 | $23.20 | $22.89 | 257,656 | 01-22-2020 |
$ | $22.52 | $22.58 | $22.73 | $22.50 | 172,362 | 01-21-2020 |
$ | $22.62 | $22.75 | $22.76 | $22.55 | 272,208 | 01-20-2020 |
$ | $22.62 | $22.75 | $22.76 | $22.55 | 272,208 | 01-17-2020 |
$ | $22.62 | $22.82 | $23.05 | $22.57 | 482,974 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 78.0% to $0.58749 on volume of 130,454,575 shares Ocean Power Technologies Inc. (OPTT) rose 29.6% to $0.2073 on volume of 51,927,154 shares Cosmos Health Inc. (COSM) rose 64.9% to $1.12 on volume of...
Company Announcement Positive CHMP opinion based on results from the Phase 1/2 EPCORE ® NHL-1 study FL is the second most common type of NHL and accounts for approximately 20-30 percent of all global cases If approved, epcoritamab (TEPKINLY ® ...
2024-06-27 09:00:08 ET Kaveri Pohlman from BTIG issued a price target of $47.00 for GMAB on 2024-06-27 07:34:00. The adjusted price target was set to $47.00. At the time of the announcement, GMAB was trading at $25.67. The overall price target consensus is at $41.80 with...